Nadia Anastasi

Nadia Anastasi is a Principal Associate at Roche, with experience dating back to September 2006, where the focus includes the development and optimization of High Throughput Screening (MTS) and in vitro functional assays to validate lead compound activities. Notable contributions involve the identification of specific ligands related to Autism Spectrum Disorders and conducting various assays such as FRET, ELISA, and Western blotting. Prior to Roche, Nadia worked as a Technician at Carex from September 2001 to May 2006, contributing to the development of assays targeting CB1 and PPAR nuclear receptors for metabolic diseases. Educational background includes a BTS in Biochimie from Jean Rostand and ongoing studies in Animal License Level 2 and neuronal cell culture at Université de Strasbourg.